Research Paper Volume 14, Issue 24 pp 9951—9968
A nomogram for predicting prognosis of multiple myeloma patients based on a ubiquitin-proteasome gene signature
Figure 9. Validation the prognostic nomogram in the validation set (GSE136377). (A) A time-dependent ROC analysis for 1-, 3-, and 5-years OS prediction. (B) Survival analysis between low-risk and high-risk MM patients. (C)The relative proportion of alive and death cases between two groups.